Skip to main content
Clinical Trials/ACTRN12620000937910
ACTRN12620000937910Completed未知

Does the intra-operative use of advanced platelet-rich fibrin (A-PRF) improve post-operative outcomes in third molar surgery?

Dr Jesslyn Praganta0 sites70 target enrollmentStarted: September 21, 2020Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
16 Years to 40 Years (—)
Sex
All

Inclusion Criteria

  • 16-40 years of age (inclusive)
  • -Healthy patients (ASA I or ASA II)
  • -Requires removal of bilateral symmetrically impacted mandibular third molars
  • -Consents to having IVS and LA for the third molar surgery

Exclusion Criteria

  • -Patients with known systemic disorders such as cardiac, hepatic, endocrine, renal or
  • bleeding disorders that are deemed to be classified as ASA III and ASA IV
  • -Patients on anticoagulant / antiplatelet therapy
  • -Patients who received dental treatment or surgery in the past 4 weeks
  • -Patients who are allergic to or cannot tolerate paracetamol, non-steroidal anti-
  • inflammatory drugs, codeine, corticosteroids, or adrenaline-containing lignocaine
  • -Pregnant or lactating patients
  • -Pre-existing local infection with associated swelling around third molars
  • -Patients refusing to undergo IVS&LA, be involved in the study and/or unable to attend
  • follow-up appointments

Investigators

Sponsor
Dr Jesslyn Praganta

Similar Trials